Dashboard PDUFA PDUFA History Dilution Watch Downside Radar Missed Milestones Earnings Big Movers Blog

🎤 Upcoming Biotech Conferences

Loading conferences...
Free to browse, no account needed Follow the companies behind these drugs with free AI briefings, catalyst countdowns and dilution alerts.

Fexofenadine · Childrens Allegra Allergy, Childrens Allegra Hives

Small molecule · Antagonist of Histamine H1 receptor (HRH1) · developed by Chattem Sanofi

Approved FDA, Jan 2011
1 Registered trials

What is Fexofenadine?

Fexofenadine is a second-generation selective histamine H1 receptor antagonist that competitively and reversibly blocks peripheral H1 receptors in the gastrointestinal tract, blood vessels and bronchial smooth muscle. It also interferes with mast cell mediator release. It is studied in drug interaction research, and is used for allergic conditions such as hives and hay fever.

Summary written with AI from the sources listed at the end of this page.

At a glance

Also known as
Childrens Allegra Allergy, Childrens Allegra Hives
Drug type
Small molecule
Targets
Histamine H1 receptor (HRH1)
Mechanism
Antagonist of Histamine H1 receptor (HRH1)
Pathways
histamine signaling, mast cell mediator release, leukotriene and prostaglandin pathways, platelet activating factor activity
Therapy area
Dermatology, Immunology, Respiratory
Developer
Chattem Sanofi
In trials of
LXRX, OGN
FDA status
Approved as Childrens Allegra Allergy, Childrens Allegra Hives (January 24, 2011), NDA201373 · FDA label
UNII
E6582LOH6V

✅ FDA-approved uses

From the indications section of the FDA label (version of May 1, 2026). Read the full label for the exact wording, limitations and safety information.

🧪 Clinical trials

TrialPhaseConditionStatusSponsor
NCT02157558 Phase 1 Drug Interactions Completed LXRX

Trials of the companies BioRadar tracks, from ClinicalTrials.gov, most advanced phase first.

Conditions studied

Drug Interactions

Other drugs acting on HRH1

Sources

Updated Nov 15, 2026.

Data: FDA (Drugs@FDA, Purple Book, DailyMed), NIH (NCI Thesaurus, GSRS, RxNorm), ClinicalTrials.gov • Informational purposes only, not medical or investment advice. • All drugs A–Z

This data is for informational purposes only, not investment advice. BioRadar does not provide buy/sell recommendations. Past performance does not guarantee future results. Always do your own due diligence.